Pallas Capital Advisors LLC Sells 5,657 Shares of Humana Inc. $HUM

Key Points

• Pallas Capital Advisors LLC reduced its stake in Humana Inc. by 70.1% during the second quarter, selling 5,657 shares and ending up with 2,415 shares worth $590,000.
• Analysts are generally cautious on Humana's stock, with several firms reducing their price targets; the average price target now stands at $289.24 with a consensus "Hold" rating.
• Humana recently announced a quarterly dividend of $0.885, translating to an annualized dividend of $3.54 and a yield of 1.4%.

Pallas Capital Advisors LLC decreased its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 70.1% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,415 shares of the insurance provider's stock after selling 5,657 shares during the period. Pallas Capital Advisors LLC's holdings in Humana were worth $590,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its position in shares of Humana by 8.9% in the 1st quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider's stock valued at $3,697,222,000 after acquiring an additional 1,143,662 shares during the period. AQR Capital Management LLC raised its position in shares of Humana by 3,257.5% in the 1st quarter. AQR Capital Management LLC now owns 1,162,600 shares of the insurance provider's stock valued at $307,624,000 after acquiring an additional 1,127,973 shares during the period. GAMMA Investing LLC raised its position in shares of Humana by 40,881.1% in the 1st quarter. GAMMA Investing LLC now owns 781,099 shares of the insurance provider's stock valued at $2,066,790,000 after acquiring an additional 779,193 shares during the period. Nuveen LLC bought a new stake in Humana during the 1st quarter worth approximately $171,220,000. Finally, Dodge & Cox raised its holdings in Humana by 5.5% during the 1st quarter. Dodge & Cox now owns 10,755,215 shares of the insurance provider's stock worth $2,845,830,000 after buying an additional 557,175 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Price Performance

Shares of NYSE:HUM traded up $1.76 on Tuesday, hitting $259.63. The company's stock had a trading volume of 287,197 shares, compared to its average volume of 1,742,860. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. The company has a market capitalization of $31.23 billion, a PE ratio of 19.91, a PEG ratio of 1.48 and a beta of 0.44. The company has a 50-day simple moving average of $269.18 and a 200 day simple moving average of $257.22. Humana Inc. has a 1 year low of $206.87 and a 1 year high of $324.38.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The firm had revenue of $32.39 billion for the quarter, compared to analysts' expectations of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The business's quarterly revenue was up 9.6% on a year-over-year basis. During the same period in the prior year, the business posted $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. Sell-side analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.4%. The ex-dividend date is Friday, September 26th. Humana's dividend payout ratio (DPR) is presently 27.17%.

Analyst Ratings Changes

Several brokerages have recently weighed in on HUM. Wells Fargo & Company decreased their price target on shares of Humana from $348.00 to $344.00 and set an "overweight" rating for the company in a research note on Thursday, August 14th. Piper Sandler cut their price target on Humana from $288.00 to $272.00 and set a "neutral" rating for the company in a report on Thursday, July 31st. Royal Bank Of Canada raised their price target on Humana from $283.00 to $322.00 and gave the company an "outperform" rating in a report on Thursday, August 21st. Wall Street Zen downgraded Humana from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Finally, Sanford C. Bernstein raised their price target on Humana from $269.00 to $341.00 and gave the company an "outperform" rating in a report on Friday, September 5th. Seven investment analysts have rated the stock with a Buy rating and seventeen have assigned a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $289.50.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.